Register entry
Janssen Cilag SpA
- Registered sites
- 0
- Drug products
- 11
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Acetaminophen 325 mg Guaifenesin 200 mg | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, and Phenylephrine hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Guaifenesin, and Phenylephrine hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride and Phenylephrine Hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
| - | Phenylephrine Hydrochloride | TABLET | DRUG FOR FURTHER PROCESSING |
| - | Phenylephrine Hydrochloride | TABLET | DRUG FOR FURTHER PROCESSING |
| - | dimethyl fumarate | CAPSULE, GELATIN COATED | DRUG FOR FURTHER PROCESSING |
| - | diphenhydramine hydrochloride | TABLET, FILM COATED | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.